· Published by Health Canada · Official notice
Healthcare professionals (medical oncologists, haematologists, oncology nurses, pharmacists), chiefs of medicine in hospitals, hospital pharmacy chiefs, cancer clinics.
| Table 1 - ERWINASE VIAL LABEL | ||
|---|---|---|
| Section of the label | UK | Canada |
| Name of Product |
Erwinase® 10,000 Units Lyophilisate for solution for injection 10,000 Units /vial |
Erwinase® 10 000 U. Sterile freeze-dried powder |
| Crisantaspase (asparaginase from Erwinia chrysanthemi, Erwinia L-asparaginase) | Erwinia L-asparaginase | |
| Reconstitution | Reconstitute before use. | Dissolve in 1 or 2 mL of Sodium chloride Injection, USP. |
| Marketing Authorization Holder |
Porton Biopharma Limited Porton Down Salisbury, SP4 0JG |
EUSA Pharma SAS |
| Excipients |
Sodium Chloride, Glucose Monohydrate |
Not reported on the vial label |
| Distributor/Local Representative | EUSA Pharma (Europe) Ltd. |
CGF Pharmatech Inc. Montreal Canada |
| MA number | PL44403/002 | DIN 02237815 |
| Others | No other information on vial label | Refer to the enclosed information leaflet |
| Table 2 - BOX LABEL | ||
|---|---|---|
|
Section All |
UK English only |
Canada French Translation |
| Name of Product | Erwinase® 10,000 Units Lyophilisate for solution for injection |
Erwinase® 10 000 U. Sterile freeze-dried powder Antileukemic |
| Crisantaspase (asparaginase from Erwinia chrysanthemi, Erwinia L-asparaginase) | Erwinia L-asparaginase for injection | |
|
Each vial contains: 10,000 Units crisantaspase |
Each vial contains: Erwinia L-asparaginase 10,000 Units |
|
| Marketing Authorization Holder (MAH) |
Porton Biopharma Limited Porton Down Salisbury, SP4 0JG |
EUSA Pharma SAS Limonest, France, 69760 |
| Excipients |
Sodium Chloride, Glucose Monohydrate |
Glucose 5.0 mg; Sodium chloride 0.5 mg |
| Reconstitution | Reconstitute before use. |
Dissolve in 1 or 2 mL of Sodium chloride Injection USP. Gently agitate to dissolve. Use only if clear. |
| Distributor/Local Representative | EUSA Pharma (Europe) Ltd. | CGF Pharmatech Inc. Montreal Quebec, H4T 1A7 |
| MA number | PL44403/002 | DIN 02237815 |
| Others |
Contains no preservative. For dosage and directions for use see package insert. |
|